Analyses of data from the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project are providing understanding on trends in utilization of simple prostatectomy for treatment of symptomatic BPH and addressing the gap in information about its outcomes.
When choosing a life insurance product, time needs to be spent on the intricacies of how those death benefits pass to the intended heirs, and how your estate is impacted, prior to making the purchase.
The Painters clear up confusion surrounding coding for prostate needle biopsy, and also discuss split billing for urodynamics testing.
Neither option will sidestep the need for a manual review prior to payment, say Ray Painter, MD, and Mark Painter.
A recent UCLA study suggests that physicians need to improve treatment counseling for patients with prostate cancer, a leading expert says.
Catch up on February’s best-read Urology Times articles, including our coverage of the AUA’s recent statement on NPs/PAs, a malpractice case involving removal of a cancer-free testicle, and a Q&A on diversity in urology.
The benefits of robot-assisted partial nephrectomy outweigh the health care and surgical costs, a new study found.
Earlier, more aggressive radiation therapy is recommended in prostate cancer patients with detectable PSA following radical prostatectomy, say the authors of a recently published study.
The muddy waters of patient selection and timing of post-prostatectomy radiation therapy may be clearer. Find out how.
A newer androgen receptor blocker significantly increases survival versus a first-generation agent in men with metastatic castration-resistant prostate cancer, data show.
Urologists attending the 2015 Urology Joint Advocacy Conference will have the opportunity to make their voices heard on Capitol Hill at a pivotal time for physicians.
Blood vessel calcification may increase risk of heart disease in patients with recurrent kidney stones, according to a recent study.
Two advisers to Urology Times are among the 2015 AUA annual award recipients.
The adage, “If at first you don’t succeed, try, try again,” does not appear to hold true when it comes to anticholinergic drug use in overactive bladder patients with urinary incontinence, recent study results indicate.
This article provides a real-world definition of refractory overactive bladder and its prevalence, then examines treatment options, with a focus on percutaneous tibial nerve stimulation as a noninvasive form of neuromodulation “for the masses.”
The analysis looked at intracytoplasmic sperm injection use and reproductive outcomes between 1996 and 2012. fertilization. Learn why
A literature review has found no evidence that testosterone therapy increases cardiovascular risk.
A patient with an abnormal PSA level transferred to another physician's care and was never told of his result. Two and a half years later, a biopsy revealed Gleason 9 prostate cancer.
Use of the urethral lift as a treatment for BPH provided rapid improvement in symptoms, flow, and quality of life that were sustained at 2 years in a multicenter study.
While questions and concerns about the use of advanced practice providers (APPs) in urology remain, the AUA's new consensus statement on the use of APPs provides a best practices framework for urology practices. Here are eight take-homes from the statement.
Advanced practice providers should be viewed as skilled members of a health care team who are filling a vital need, writes Urology Times Group Content Director Richard R. Kerr.
A large-scale study provides new evidence that targeted MRI ultrasound fusion prostate biopsy increases detection of high risk prostate cancers while decreasing detection of low-risk cancers. "More reliable diagnosis"
In this blog post, Dr. Henry Rosevear ponders the relationship between drug reps and urologists.
A newly published analysis “opens a huge opportunity for the discovery of new biomarkers” for multiple cancers, including aggressive prostate cancer, a leading urologic cancer expert says.
More than 90% of men whose lower urinary tract symptoms (LUTS) progress do not seek treatment for their symptoms, according to recent study results that one expert cautioned against overinterpreting.
Robot-assisted prolapse surgery for apical multicompartment vaginal prolapse repair is a safe procedure with durable outcomes, according to a retrospective study undertaken by urologists at Beaumont Hospital, Royal Oak, MI.
Palmetto GBA, a national contractor that administers Medicare benefits, has issued a positive coverage policy through the MolDX Program for the Decipher prostate cancer classifier, developer GenomeDx Biosciences reported.
Urologists contacted by Urology Times do not expect the current makeup of Congress to have much of an impact on health care.
More work needs to be done to expand the role of minorities and women in urology leadership positions and to stay competitive with other specialties, Tracy M. Downs, MD, explains in this interview.